A therapeutic approach that reprograms cancer cells epigenetically to reduce malignancy, halt growth, and induce natural cell death, targeting treatment-resistant cancers like glioblastoma.

Research and development of Procyanidin C1, a natural compound that selectively removes senescent cells to extend lifespan and improve healthspan through senolytic and senomorphic effects.